P2X purinergic receptor antagonist accelerates skin barrier repair and prevents epidermal hyperplasia induced by skin barrier disruption

Journal of Investigative Dermatology

Volumn 119, Issue 5, 2002, Pages 1034-1040

  Denda, Mitsuhiro ^a   Inoue, Kaori ^a   Fuziwara, Shigeyoshi ^a   Denda, Sumiko ^a  

^a SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

ATP; Barrier homeostasis; Calcium; Epidermis; Keratinocyte; Stratum corneum

Indexed keywords

2',3' O (2,4,6 TRINITROPHENYL)ADENOSINE 5' TRIPHOSPHATE; ADENOSINE DERIVATIVE; ADENOSINE TRIPHOSPHATE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; CATION; CIBACRON BLUE F3GA; M PROTEIN; PURINERGIC RECEPTOR BLOCKING AGENT; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; SURAMIN; UNCLASSIFIED DRUG;

AGONIST; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CELL DISRUPTION; CONTROLLED STUDY; CONVALESCENCE; DRUG ANTAGONISM; ENVIRONMENT; ENZYME RELEASE; EPIDERMIS; EPIDERMIS HYPERPLASIA; HOMEOSTASIS; HUMAN; HUMAN CELL; HUMIDITY; IMMUNOHISTOCHEMISTRY; INFANT; KERATINOCYTE; MALE; MOUSE; NONHUMAN; NUDE MOUSE; ORGAN CULTURE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN CARE;

EID: 0036445493     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.19505.x     Document Type: Article

References (50)

1. Ashida Y, Denda M, Hirao T: Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol 116:261-265, 2001a
2. Ashida Y, Ogo M, Denda M: Epidermal interleukin-1 generation is amplified at low humidity: Implications for the pathogenesis of inflammatory dermatoses. Br J Dermatol 144:238-243, 2001b
3. Burnstock G, Williams M: P2 purinergic receptors: Modulation of cell function and therapeutic potential. J Pharmacol ExpTherap 295:862-869, 2000
4. Cockayne DA, Hamilton SG, Zhu QM, et al: Urinary bladder hyporeflexia and reduced pain-related behavior in P2X3-deficient mice. Nature 407:1011-1015, 2000
5. Denda M, Kumazawa N: Negative electric potential induces alteration of ion gradient and lamellar body secretion in the epidermis, and accelerates skin barrier recovery after barrier disruption. J Invest Dermatol 118:65-72, 2002
6. Denda M, Tsuchiya T: Barrier recovery rate varies time-dependently in human skin. Br J Dermatol 142:881-884, 2000
7. Denda M, Kitamura K, Elias PM, Feingold KR: Trans-4-(aminomethyl) cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans. J Invest Dermatol 109:84-90, 1997
8. Denda M, Sato J, Masuda Y, et al: Exposure to a dry environment enhances epidermal permeability barrier function. J Invest Dermatol 111:858-863, 1998a
9. Denda M, Sato J, Tsuchiya T, Elias PM, Feingold KR: Low humidity stimulates epidermal DNA synthesis and amplifies the hyperproliferative response to barrier disruption: Implication for seasonal exacerbations of inflammatory dermatoses. J Invest Dermatol 111:873-878, 1998b
10. Denda M, Hosoi J, Ashida Y:Visual imaging of ion distribution in human epidermis. Biochem Biophys Res Commun 272:134-137, 2000
11. Denda M, Fuziwara S, Inoue K, Denda S, Akamatsu H, Tomitaka A, Matsunaga K: Immunoreactivity of VR1 on epidermal keratinocyte of human skin. Biochem Biophys Res Commun 285:1250-1252, 2001
12. Dixon CJ, Bowler WB, Littlewood-Evans A, Dillon JP, Bilbe G, Sharpe GR, Galla-gher JA: Regulation of epidermal homeostasis through P2Y2 receptors. Br J Pharmacol 127:1680-1686, 1999
13. Elias PM, Feingold KR: Coordinate regulation of epidermal differentiation and barrier homeostasis. Skin Pharmacol Appl Skin Physiol 14:S28-S34, 2001
14. 2+ concentration induced by mechanical stimulation is propagated via release of pyrophosphorylated nucleotides in mammary epithelial cells. Pflugers Arch 427:533-542, 1994
15. Evans JH, Sanderson MJ: Intracellular calcium oscillations induced by ATP in airway epithelial cells. Am J Physiol 277:L30-L41, 1999
16. Ferguson DR, Kennedy I, Burton TJ: ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes - A possible sensory mechanism? J Physiol 505:503-511, 1997
17. Forslind B, Werner-Linde Y, Lindberg M, Pallon J: Elemental analysis mirrors epidermal differentiation. Acta Derm Venereol (Stockh) 79:12-17, 1999
18. Genever PG, Maxfield SJ, Kennovin GD, Maltman J, Bowgen CJ, Raxworthy MJ, Skerry TM: Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. J Invest Dermatol 112:337-342, 1999
19. Glass R, Townsend-Nicholson A, Burnstock G: P2 receptors in the thymus: Expression of P2X and P2Y receptors in adult rats, an immunohistochemical and in situ hybridization study. Cell Tissue Res 300:295-306, 2000
20. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450, 1985
21. Guo A, Vulchanova L, Wang XL, Elde R: Immunocytochemical localization of the vanilloid receptor 1 (VR1): Relationship to neuropeptides, the P2X3 purinoceptor and IB4 binding sites. Eur J Neuroscience 11:946-958, 1999
22. Homolya L, Steinberg TH, Boucher RC: Cell to cell communication in response to mechanical stress via bilateral release of ATP and UTP in polarized epithelia. J Cell Biol 150:1349-1359, 2000
23. Hu Z, Bonifas JM, Beech J, et al: Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nature Genet 24:61-65, 2000
24. Karvonen SL, Korkiamaki T, Yla-Outinen H, et al: Psoriasis and altered calcium metabolism: Downregulated capacitative calcium influx and defective calcium-mediated cell signaling in cultured psoriatic keratinocytes. J Invest Dermatol 114:693-700, 2000
25. Koizumi S, Inoue K: Inhibition by ATP of calcium oscillations in rat cultured hippocampal neurons. Br J Pharmacol 122:51-58, 1997
26. Lee SH, Elias PM, Proksch E, Menon GK, Man MQ, Feingold KR: Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 89:530-538, 1992
27. Lee SH, Elias PM, Feingold KR, Mauro T: A role for ions in barrier recovery after acute perturbation. J Invest Dermatol 102:976-979, 1994
28. Liang SX, Jenkins NA, Gilbert DJ, Copeland NG, Phillips WD: Structure and chromosome localization of the mouse P2X1 purinoceptor gene. Cytogenet Cell Genet 92:333-336, 2001
29. + gradients in murine epidermis: Quantitative measurement using PIXE. J Invest Dermatol 111:1198-1201, 1998
30. Menon K, Price LF, Bommannan B, Elias PM, Feingold KR: Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion. J Invest Dermatol 102:789-795, 1994
31. Mitchell CH: Release of ATP by a human retinal pigment epithelial cell line: Potential for autocrine stimulation through subretinal space. J Physiol 534:193-202, 2001
32. National Research Council (NRC): National Research Council Guide,Washington: National Academy Press, 1996
33. Ndoye A, Buchli R, Greenberg B, et al: Identification and mapping of keratinocyte muscarinic acetylcholine receptor subtypes in human epidermis. J Invest Derma-tol 111:410-416, 1998
34. Nemes Z, Steinert PM: Bricks and mortar of the epidermal barrier. Exp Mol Med 31:5-19, 1999
35. Pillai S, Bikle DD: Adenosine triphosphate stimulates phosphoinositide metabolism, mobilizes intracellular calcium and inhibits terminal differentiation of human epidermal keratinocytes. J Clin Invest 90:42-51, 1992
36. Proksch E, Feingold KR, Man MQ, Elias PM: Barrier function regulates epidermal DNA synthesis. J Clin Invest 87:1668-1673, 1991
37. 2+ pump, cause Darier disease. Nature Genet 21:271-277, 1999
38. Schwiebert EM, Wallace DP, Braunstein GM, et al: Autocrine extracellular purinergic signaling in epithelial cells derived from polycystic kidneys. Am J Physiol 282:763-F775, 2001
39. Shepherd GM: The synapse. In: Neurobiology. Oxford, UK: Oxford University Press, 1994: pp 102-131
40. Souslova V, Ravenall S, Fox M, Wells D, Wood JN, Akopian AN: Structure and chromosomal mapping of mouse P2X3 gene. Gene 195:101-111, 1997
41. Souslova V, Cesare P, Ding Y, et al: Warm-coding deficits and aberrant inflammatory pain in mice lacking P2X3 receptors. Nature 407:1015-1017, 2000
42. Stoebner PE, Carayon P, Penarier G, et al: The expression of peripheral benzodiapine receptors in human skin: The relationship with epidermal cell differentiation. Br J Dermatol 140:1010-1016, 1999
43. Virginio C, Robertson G, Surprenant A, North RA: Trinitrophenyl-substituted nucleotides are potent antagonists selective for P2X1, P2X3 and heteromeric P2X2/3 receptors. Mol Pharmacol 53:696-673, 1998
44. Watanabe R, Wu K, Paul P, Marks DL, Kobayashi T, Pittelkow MR, Pagano RE: Up-regulation of glucosylceramide synthase expression and activity during human keratinocyte differentiation. J Biol Chem 273:9651-9655, 1998
45. Watson J, Brough S, Coldwell MC, et al: Functional effects of the muscaric receptor agonist, xanomeline, at 5-HT1 and 5HT2 receptors. Br J Pharmacol 125:1413-1420, 1998
46. Wood LC, Jackson SM, Elias PM, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-478, 1992
47. Wood LC, Elias PM, Calhoun C, Feingold KR: Barrier disruption stimulates interleukin-1 alpha expression and release from a preformed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
48. Worthington RA, Dutton JL, Poronnik P, Bennett MR, Barden JA: Localization of P2X receptors in human salivary gland epithelial cells and human embryonic kidney cells by sodium dodecyl sulfate-polyacrylamide gel electrophoresis/Western blotting and immunofluorescence. Electrophoresis 20:2065-2070, 1999
49. Yuspa SH, Hennings H, Tucker RW, Jaken S, Kilkenny AE, Roop DR: Signal transduction for proliferation and differentiation in keratinocytes. Ann NY Acad Sci 548:191-196, 1988
50. Zhang PC, Keleshian AM, Sachs F: Voltage-induced membrane movement. Nature 413:428-431, 2001